4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-012223
Director acquired 747 shares (code L)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jones James Director | 2023-08-16 | Other acquisition 10b5-1 | +65 | $1.64 | $107 | 27,358 | D |
| Jones James Director | 2023-08-17 | Other acquisition 10b5-1 | +65 | $1.70 | $111 | 27,423 | D |
| Jones James Director | 2023-08-18 | Other acquisition 10b5-1 | +65 | $1.70 | $111 | 27,488 | D |
| Jones James Director | 2023-08-21 | Other acquisition 10b5-1 | +65 | $1.68 | $109 | 27,553 | D |
| Jones James Director | 2023-08-22 | Other acquisition 10b5-1 | +65 | $1.72 | $112 | 27,618 | D |
| Jones James Director | 2023-08-23 | Other acquisition 10b5-1 | +65 | $1.70 | $111 | 27,683 | D |
| Jones James Director | 2023-08-24 | Other acquisition 10b5-1 | +27 | $1.69 | $46 | 27,710 | D |
| Jones James Director | 2023-08-25 | Other acquisition 10b5-1 | +65 | $1.70 | $111 | 27,775 | D |
| Jones James Director | 2023-08-28 | Other acquisition 10b5-1 | +65 | $1.71 | $111 | 27,840 | D |
| Jones James Director | 2023-08-29 | Other acquisition 10b5-1 | +70 | $1.67 | $117 | 27,910 | D |
| Jones James Director | 2023-08-30 | Other acquisition 10b5-1 | +65 | $1.68 | $109 | 27,975 | D |
| Jones James Director | 2023-08-31 | Other acquisition 10b5-1 | +65 | $1.67 | $109 | 28,040 | D |
Loading xslF345X05/marketforms-62531.xml…